Lisy Wang - Concepedia

Author

Lisy Wang

Pfizer (United States)ORCID

Also Known As

Lisy Wang

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Seoul National University Metroplex Clinical Research Center The University of Texas Southwestern Medical Center Pfizer (Canada)

About

Lisy Wang is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacodynamic modeling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	24
2	Allergy	1	1	24
3	Allergy Medicine	1	1	24
4	Nephrology	1	1	24
5	Pharmacology	1	1	24

Lisy Wang

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, Annals of the Rheumatic Diseases	2017	381
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis, Arthritis Research & Therapy	2019	313
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Annals of the Rheumatic Diseases	2021	234
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey, Arthritis & Rheumatology	2017	232
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme Stanley Cohen, Yoshiya Tanaka, Xavier Mariette, RMD Open	2020	170
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies Hendrik Schulze‐Koops, Vibeke Strand, Chudy I. Nduaka, Lara D. Veeken	2016	78
Epidermal Expression of Collagenase Delays Wound-Healing in Transgenic Mice Teresa Di Colandrea, Kiran Chada, Lisy Wang, Journal of Investigative Dermatology	1998	57
Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis Ronald van Vollenhoven, Eun Bong Lee, Sander Strengholt, Arthritis & Rheumatology	2018	50
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies R. Fleischmann, J. Wollenhaupt, Liza Takiya, RMD Open	2017	41
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites Ellen Q. Wang, Vu Le, Melissa O’Gorman, The Journal of Clinical Pharmacology	2021	38

Page 1